Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance. - Wikidata - wikimedia - TriplyDB

Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance.

Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance.

http://www.wikidata.org/entity/Q37611624

about

The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.Carboxylesterases in lipid metabolism: from mouse to human.Lipidomics unveils the complexity of the lipidome in metabolic diseases.

P2860

Q33602919-5B083C21-DB87-4EEA-B42E-15DFAB7A09D0 Q39414484-5F8F6AAF-3A27-4B44-A2A5-D31BC954036C Q48157430-C5A99E2E-5403-48A6-BADA-64A774404222

P2860

Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance.

http://www.wikidata.org/entity/Q37611624

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Human Carboxylesterase 2 Rever ...... ation and Glucose Intolerance.

@en

Human Carboxylesterase 2 Rever ...... ation and Glucose Intolerance.

@nl

type

label

Human Carboxylesterase 2 Rever ...... ation and Glucose Intolerance.

@en

Human Carboxylesterase 2 Rever ...... ation and Glucose Intolerance.

@nl

prefLabel

Human Carboxylesterase 2 Rever ...... ation and Glucose Intolerance.

@en

Human Carboxylesterase 2 Rever ...... ation and Glucose Intolerance.

@nl

P1433

Q37611624-29C07E4B-5E9B-46F8-A100-4593BF49F3C9

P1476

Q37611624-485FB78C-BF16-4A35-A7BE-B67A08842B18

P2093

Q37611624-391B1E16-3769-483A-A0F4-0D664A13D63A

Q37611624-3DAF86BE-D205-48CB-9E9E-DEC6B673F3C6

Q37611624-46C2F1BE-AF8A-47D6-8147-92A9FD46BEEA

Q37611624-A741A3B7-74A0-4B89-9782-2AD82C8629F0

Q37611624-C9B5E6DE-07BC-42AA-98E3-E4EB64D07236

Q37611624-CFAFD91C-4B3D-4A78-98AD-01FCA617B432

P2860

Q37611624-09C244DF-D6BF-4F54-A80C-AA5F032FA049

Q37611624-0BCD47ED-3CB4-4D5C-B996-DA1E8AD2DBFA

Q37611624-195EB10B-C885-4D00-86E3-7F1C98B82BB9

Q37611624-2D098221-9AE2-4CC5-9448-2E6FF4367CF1

Q37611624-2EA60922-C244-43A8-B14C-47F8FFD07C24

Q37611624-370B79EC-4BBB-4FDF-9E4B-0D51EAFF42F6

Q37611624-394CB85C-F8F4-4BA2-92C0-966863F571FD

Q37611624-3A0D69C6-C345-48D7-BCCD-FA0772DAE2D1

Q37611624-3B832152-09CE-4213-9A71-7434730152E5

Q37611624-4122FC60-E85E-4F87-863B-2C839452F1C4

P304

Q37611624-0319DAE3-1F94-463B-AD79-561301C9505B

P31

Q37611624-D9BD9C3D-D6EB-4B22-94E4-21472C23C5F7

P356

Q37611624-0896AB73-B0D3-40B0-BD66-C2C51A7C7840

P433

Q37611624-55C8E431-EABD-4D3F-8D3B-48DFF3E89D53

P478

Q37611624-730498F0-5C89-4363-B9D0-72744CAE1015

P50

Q37611624-09CB00EC-D78C-4337-95C0-47BD286A9142

Q37611624-102BDDF2-617C-4D7B-A9C9-F9A3F8B8BB4B

Q37611624-12C56AC9-EEE8-4644-9889-0C729E761A90

Q37611624-E6B057BB-AC09-4773-9703-C8D61711B77E

P577

Q37611624-369F31DF-AE69-430F-AFC0-7EBF19D5044A

P698

Q37611624-9A781FB9-6645-478B-91C7-E522C6495CC6

P921

Q37611624-8FAA6D5B-09D9-4DFC-8773-B351BD4DC6F0

Q37611624-a454aa83-12c8-4afb-a7ae-43a81f485fc4

P932

Q37611624-EA2855F5-5803-4F3F-B6E8-F62018AC138D

P356

J.CELREP.2016.12.070

P1433

P1476

Human Carboxylesterase 2 Rever ...... ation and Glucose Intolerance.

@en

P2093

Daniel K Nomura

http://www.w3.org/2001/XMLSchema#string

Devon M Hunerdosse

http://www.w3.org/2001/XMLSchema#string

Erik Näslund

http://www.w3.org/2001/XMLSchema#string

Jorge C Correia

http://www.w3.org/2001/XMLSchema#string

Milena Schönke

http://www.w3.org/2001/XMLSchema#string

Sharon M Louie

http://www.w3.org/2001/XMLSchema#string

P2860

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

Chemical probes of endocannabinoid metabolism

Emerging roles for lysophosphatidylserine in resolution of inflammation

GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity

Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes

Enzymatic measurement of phosphatidylglycerol and cardiolipin in cultured cells and mitochondria

Arylacetamide deacetylase attenuates fatty-acid-induced triacylglycerol accumulation in rat hepatoma cells

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes

Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay.

P304

636-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2016.12.070

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Juleen R Zierath

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28099843

http://www.w3.org/2001/XMLSchema#string

P921

P932

5276805

http://www.w3.org/2001/XMLSchema#string